ARCHIVES

Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

A Provision Of The EARLY Bill Is Inserted Into House Appropriations For Labor, HHS

July 24, 2009

In Brief: Deadline June 1 For Cancer Research Institute Grants; Chabner To Present Karnofsky Lecture

May 3, 1985

In Brief: NCI To Supply Maytansine For Several Phase I Studies; Holleb Urges Referrals To “Experts”

March 26, 1976

Radio-Immunotherapy Advances May Rival Those With Drugs

April 16, 1976

Aggressive Cancer Screening Increases Overdiagnosis, JAMA Paper Argues

October 30, 2009

Pryor Calls For Price Regulation Of Drugs In Health Reform

February 12, 1993